Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by IainCaimbeulon Jun 20, 2023 4:32pm
76 Views
Post# 35506030

RE:RE:Warrants

RE:RE:Warrants
Nailbiter2 wrote:
A number of shareholders have asked if thy could extend the expiration date of the warrants and also reduce the exercise price of the warrants.  Generally, shareholders obtain warrants as part of a private placement.
 
They have extended the expiration date on some warrants earlier this year.  However, for the ones coming up this was the best way to manage it and also allow individuals to exercise their warrants rather than have them just expire.
 
It is a time consuming process to get permission to change any aspect of the warrants and you will see in the press release that they were unable to make any changes to the listed warrants.
 
This is a good thing as there are shareholders who will exercise their warrants rather than lose them and that will put money into StageZero.  The press release was put out as part of the regulatory requirements when dealing with warrants.



"This is a good thing as there are shareholders who will exercise their warrants rather than lose them and that will put money into StageZero."
Check my earlier post; at 6.5 cents exercise price and best warrant price of .5 cents you would be paying almost double the current share price. In what universe would that make sense? 
<< Previous
Bullboard Posts
Next >>